Your browser doesn't support javascript.
loading
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
Dyall, Julie; Coleman, Christopher M; Hart, Brit J; Venkataraman, Thiagarajan; Holbrook, Michael R; Kindrachuk, Jason; Johnson, Reed F; Olinger, Gene G; Jahrling, Peter B; Laidlaw, Monique; Johansen, Lisa M; Lear-Rooney, Calli M; Glass, Pamela J; Hensley, Lisa E; Frieman, Matthew B.
Afiliação
  • Dyall J; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Coleman CM; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hart BJ; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Venkataraman T; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Holbrook MR; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Kindrachuk J; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Johnson RF; Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Olinger GG; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Jahrling PB; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Laidlaw M; Zalicus Inc., Cambridge, Massachusetts, USA.
  • Johansen LM; Zalicus Inc., Cambridge, Massachusetts, USA.
  • Lear-Rooney CM; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
  • Glass PJ; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
  • Hensley LE; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
  • Frieman MB; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA MFrieman@som.umaryland.edu.
Antimicrob Agents Chemother ; 58(8): 4885-93, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24841273
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave / Bibliotecas de Moléculas Pequenas / Reposicionamento de Medicamentos / Coronavírus da Síndrome Respiratória do Oriente Médio Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave / Bibliotecas de Moléculas Pequenas / Reposicionamento de Medicamentos / Coronavírus da Síndrome Respiratória do Oriente Médio Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos